Link between urinary podocyturia and severity of pre-eclampsia
Prospective Study : Association Between Pococyturia and Pre-eclampsia Severity
This study is trying to see if measuring a specific protein in urine can help doctors understand how severe pre-eclampsia is in pregnant women.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 2 sites (Pierre-Bénite, Rhône and 1 other locations) |
| Trial ID | NCT03316391 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the correlation between urinary podocyturia levels and the severity of pre-eclampsia in pregnant women. By measuring urinary podocyturia, the study aims to provide a rapid indicator that could assist clinicians in making timely decisions regarding patient management. The study is prospective and non-interventional, focusing on women aged 18 and older who are admitted for pre-eclampsia. The goal is to enhance the understanding of pre-eclampsia severity without the delays associated with traditional proteinuria testing.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 or older with a single pregnancy who are admitted for pre-eclampsia.
Not a fit: Patients with multiple pregnancies, fetal demise, antecedent nephropathy, or those unable to understand the information provided will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to quicker and more accurate assessments of pre-eclampsia severity, improving patient management and outcomes.
How similar studies have performed: While the approach of using urinary podocyturia as a marker for pre-eclampsia severity is novel, similar studies have explored alternative biomarkers with varying degrees of success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * women aged 18 years or more * single pregnancy * admission for pre-eclampsia * patient receiving information and non-opposition to participate Exclusion Criteria: * multiple pregnancy * in utero fetal demise excepted if associated with pre-eclampsia * antecedent of nephropathy * fetal malformation, chromosomal anomalies * inability to understand information provided * prisoner or under administrative supervision
Where this trial is running
Pierre-Bénite, Rhône and 1 other locations
- Service de gynécologie-obstétrique — Pierre-Bénite, Rhône, France (Recruiting)
- Department of obstetrics, Femme Mère Enfant Hospital, Lyon, France — Bron, France (Terminated)
Study contacts
- Study coordinator: Muriel DORET-DION, MD
- Email: muriel.doret-dion@chu-lyon.fr
- Phone: 04 27 85 51 70
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.